In SCLC, antigen processing and presentation of peptide antigens via MHC-I related genes (B2M) were less activated in malignant cells of the patients with lower immune infiltration than those with higher immune infiltration, which is of great significance for elucidating the mechanisms of tumor resistance. Here, B2M is linked to small cell lung carcinoma.